Scrip is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Spinal device developer Spinal Modulation raised $27.4mm in its Series C financing led by first-time backer Johnson & Johnson Development Corp., which was joined by other new investors DFJ InCube Ventures and Raffles Venture Partners and returning shareholders De Novo Ventures, DFJ ePlanet Ventures, Kleiner Perkins Caufield & Byers, and MedVenture Associates.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?